Collegium Pharmaceutical Inc — 四半期キャッシュフロー (NASDAQ:COLL) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 1.66 B1.63 B1.59 B1.61 B1.66 B 負債合計 1.43 B1.4 B1.36 B1.33 B1.36 B 純資産合計 228.84 M234.43 M232.21 M274.81 M301.68 M 負債および純資産合計 1.66 B1.63 B1.59 B1.61 B1.66 B 有利子負債合計 852.49 M837.71 M822.92 M808.12 M809.33 M 純負債 595.53 M538.35 M495.96 M382.51 M267.22 M

ニュース

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

【決算速報】コレギウム・ファーマシューティカル、売上高は予想を下回り、利益は予想を下回る結果に

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates

Collegium Pharmaceutical決算発表控え、Jornay PMに注目集まる

Collegium Pharmaceutical earnings ahead: Jornay PM in focus

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?